[{"Assets_0_Q1_USD":134553000.0,"CommonStockSharesOutstanding_0_Q1_shares":13195616.0,"EarningsPerShareBasic_1_Q1_USD":-0.12,"EarningsPerShareDiluted_1_Q1_USD":-0.12,"NetIncomeLoss_1_Q1_USD":-1556000.0,"StockholdersEquity_0_Q1_USD":110547000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q1_shares":13064000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q1_shares":13064000.0,"Ticker":"SRDX","CIK":"924717","name":"SURMODICS INC","OfficialName":"Surmodics Inc. Common Stock","form":"10-Q","period":"20171231","fy":"2018.0","fp":"Q1","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"609353600.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Electromedical & Electrotherapeutic Apparatus","Market":"NASDAQ","SP500":"nan","filed":"20180208"}]